|
 |
|
|
|
|
|
WHAT THEY ARE SAYING
"At Dr. Oetker, we believe that quality is the best recipe. It is our belief that recent developments within IRI have served to improve both the quality of data and the quality of providing this data. As a relatively new business to the U.K., Dr. Oetker was looking for a data solution that provided accurate, impactful and relevant insights but, more importantly, would deliver a proactive approach to the relationship. "
Peter Franks
Managing Director
Dr. Oetker
|
|
All Products Detail
|
BehaviorScan Rx ad testing is the industry-recognized gold standard testing service. It delivers different TV advertisements in the same market and can link TV viewing to consumer and doctor prescription drug activity. This in-market, split cable design solution provides the most accurate measurement of the impact of DTC advertising on prescription activity. The BehaviorScan Rx ad testing package includes exclusive testing rights in a specified market, consultation on test market selection and test design, execution of test and control advertising plans via cable TV cut-ins, and analysis of results.
|
See
|
|
The impact of your advertising and gain insights from resulting prescription activity
|
Act
|
|
Evaluate and refine your advertising based on test results across markets
|
Win
|
Ensure a return on your advertising campaign investment
|
| TAKE THE NEXT STEP |
|
|
Have a question or need more information about this product? Fill out the form below and an IRI representative will contact you as soon as possible.
|
|
|
 |
|
 |
|
|
|
|
|
|
|
|
|
|
|
|